<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9013016</journal-id>
<journal-id journal-id-type="pubmed-jr-id">20859</journal-id>
<journal-id journal-id-type="nlm-ta">Behav Pharmacol</journal-id>
<journal-id journal-id-type="iso-abbrev">Behav Pharmacol</journal-id>
<journal-title-group>
<journal-title>Behavioural pharmacology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0955-8810</issn>
<issn pub-type="epub">1473-5849</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29035919</article-id>
<article-id pub-id-type="pmc">5899065</article-id>
<article-id pub-id-type="doi">10.1097/FBP.0000000000000348</article-id>
<article-id pub-id-type="manuscript">NIHMS900118</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Attenuation of compulsive-like behavior by fluvoxamine in a non-induced mouse model of obsessive-compulsive disorder</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Mitra</surname>
<given-names>Swarup</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bult-Ito</surname>
<given-names>Abel</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Department of Chemistry &amp; Biochemistry, University of Alaska Fairbanks, USA</aff>
<aff id="A2">
<label>2</label>IDeA Network of Biomedical Research Excellence (INBRE) University of Alaska Fairbanks, USA</aff>
<aff id="A3">
<label>3</label>Department of Biology &amp; Wildlife, University of Alaska Fairbanks, USA</aff>
<author-notes>
<corresp id="FN1"><label>*</label><bold>Corresponding author:</bold> Abel Bult-Ito, Ph.D., Department of Biology and Wildlife, University of Alaska Fairbanks, P.O. Box 756100, Fairbanks, AK 99775-6100, USA, Phone:1-907-978-2169, Fax: 1-907-474-6716, <email>abultito@alaska.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>25</day>
<month>8</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>6</month>
<year>2019</year>
</pub-date>
<volume>29</volume>
<issue>4</issue>
<fpage>299</fpage>
<lpage>305</lpage>
<!--elocation-id from pubmed: 10.1097/FBP.0000000000000348-->
<abstract>
<p id="P1">The current study evaluated the role of strain and compulsive trait differences in response to fluvoxamine, a common OCD drug, in two different mouse strains (BIG1 and BIG2) exhibiting a spontaneous compulsive-like phenotype. For compulsive-like nest-building behavior, dose-dependent attenuation of nesting by fluvoxamine was observed for the BIG1 compulsive-like strain during the first hour after administration. No significant differences were found for BIG2 strain during the first hour, although a dose-dependent trend similar to that seen in the BIG1 strain was observed. Fluvoxamine dose-dependently decreased the number of marbles buried in both strains one hour after administration. For anxiety-like behaviors in the open field, no significant drug effects were found for the latency to leave the center and the number of line crossings. Significant strain differences were observed, with the BIG2 strain exhibiting higher anxiety-like behaviors and reduced locomotor activity when compared to the BIG1 strain. Consequently, this study adds predictive validity to our mouse model of OCD, while the anxiety-like differences between the strains add heterogeneity to our mouse model, similar to the heterogeneity seen in OCD.</p>
</abstract>
<kwd-group>
<kwd>Fluvoxamine</kwd>
<kwd>obsessive-compulsive disorder</kwd>
<kwd>mouse model</kwd>
<kwd>strain</kwd>
<kwd>trait</kwd>
<kwd>anxiety</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>